Cancer BiologybioRxivPreprint
CUB domain containing protein 1 (CDPC1) is a target for radioligand therapy in castration resistant prostate cancer
N. Zhao, k. Trepka, Y.-h. Wang…·R. Aggarwal
This paper evaluates CDCP1 as a target for radioligand therapy in mCRPC, showing its expression in most biopsies and demonstrating antitumor effects with 177Lu-4A06.
DOI 10.1101/2021.06.17.448569